RECQL and glioblastoma: Cancer cell-specific upregulation of RECQ1 has been demonstrated in glioblastoma [53], multiple myeloma [54], ovarian cancers [55], hematological cancers [56], hepatocellular carcinoma [57], head and neck [58], and tongue squamous cell carcinoma [59].